The human milk oligosaccharide 3′sialyllactose reduces low-grade inflammation and atherosclerosis development in mice

Ariane Pessentheiner(University of Graz), Philip L.S.M. Gordts(University of Utah), Hal M. Hoffman(Rady Children's Hospital-San Diego), Chelsea D. Painter(University of California San Diego), Udo Oppermann(Oxford BioMedica (United Kingdom)), Austin W.T. Chiang(Foundation Center), Joseph L. Witztum(University of California San Diego), Christopher K. Glass(University of California San Diego), Laela M. Booshehri(University of California San Diego), Adam P. Cribbs(Centre for Human Genetics), Chloe Autran(University of California San Diego), Menno P.J. de Winther(Amsterdam University Medical Centers), Joanna Latasiewicz(University of California San Diego), Nathanael J. Spann(University of California San Diego), Bastian Ramms(University of California San Diego), Chiara Tognaccini(University of California San Diego), Ruth T. Yu(Peking University), Joanna Coker(University of California San Diego), Lisa Willemsen(Amsterdam University Medical Centers), Alexandra Hammond(University of California San Diego), Annette R. Atkins(Salk Institute for Biological Studies), Kaare V. Grunddal(University of California San Diego), Martin Philpott(Nuffield Orthopaedic Centre), Karsten Zengler(University of California San Diego), Nathan E. Lewis(University of Georgia), Lars Bode(Western Human Nutrition Research Center), Michael Downes(Salk Institute for Biological Studies), Yiwen Wang(XinHua Hospital), Chenyi Wang(Oxford BioMedica (United Kingdom)), Ron M Evans(Salk Institute for Biological Studies), Tae Gyu Oh(University of Oklahoma Health Sciences Center), Anthony Quach(University of California San Diego), Jason Hsiao(University of California San Diego)
JCI Insight
September 26, 2024
Cited by 16


Related Papers